Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |